Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan for severe acute heart failure in critically ill children
2009-017827-24Phase 2Terminated
- Sponsor
- José Luis Vázquez MartÃnez
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of levosimendan in Acute Heart Failure (AHF) (2 arms), sponsored by José Luis Vázquez MartÃnez. Primary endpoints: Hemodynamic improvement at 24 and 48 hours and Improvement in cardiac output at 24 and 48 hours. Started Dec 2009; status: terminated.
02
Drugs
levosimendan
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on 2009-017827-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017827-24.